【are beans self pollinating】When Can We Expect A Profit From Oasmia Pharmaceutical AB (publ) (STO:OASM)?
Want to help shape the future of investing tools?are beans self pollinating Participate in a
short research study
and receive a 6-month subscription to the award winning Simply Wall St research tool (valued at $60)!
Oasmia Pharmaceutical AB (publ)’s (
STO:OASM
)
: Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. The company’s loss has recently broadened since it announced a -kr118.0m loss in the full financial year, compared to the latest trailing-twelve-month loss of -kr153.3m, moving it further away from breakeven. As path to profitability is the topic on OASM’s investors mind, I’ve decided to gauge market sentiment. Below I will provide a high-level summary of the industry analysts’ expectations for OASM.
Check out our latest analysis for Oasmia Pharmaceutical
According to the industry analysts covering OASM, breakeven is near. They expect the company to post a final loss in 2019, before turning a profit of kr87m in 2020. So, OASM is predicted to breakeven approximately a few months from now. What rate will OASM have to grow year-on-year in order to breakeven on this date? Using a line of best fit, I calculated an average annual growth rate of 116%, which is extremely buoyant. If this rate turns out to be too aggressive, OASM may become profitable much later than analysts predict.
OM:OASM Past Future Earnings February 1st 19
I’m not going to go through company-specific developments for OASM given that this is a high-level summary, though, bear in mind that generally biotechs, depending on the stage of product development, have irregular periods of cash flow. This means that a high growth rate is not unusual, especially if the company is currently in an investment period.
One thing I’d like to point out is that OASM has managed its capital prudently, with debt making up 31% of equity. This means that OASM has predominantly funded its operations from equity capital,and its low debt obligation reduces the risk around investing in the loss-making company.
Next Steps:
There are key fundamentals of OASM which are not covered in this article, but I must stress again that this is merely a basic overview. For a more comprehensive look at OASM, take a look at
OASM’s company page on Simply Wall St
. I’ve also compiled a list of relevant aspects you should further research:
Valuation
: What is OASM worth today? Has the future growth potential already been factored into the price? The
intrinsic value infographic in our free research report
helps visualize whether OASM is currently mispriced by the market.
Management Team
: An experienced management team on the helm increases our confidence in the business – take a look at
who sits on Oasmia Pharmaceutical’s board and the CEO’s back ground
.
Other High-Performing Stocks
: Are there other stocks that provide better prospects with proven track records? Explore our
free list of these great stocks here
.
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at
.
View comments
下一篇:Westland Insurance Acquires Diamond Insurance Agencies in Alberta
相关文章:
- SCOR successfully sponsors a new catastrophe bond, Atlas Capital Reinsurance 2020 DAC
- Cardtronics PLC (CATM) Files 10-K for the Fiscal Year Ended on December 31, 2018
- U.S. Stock Indexes Under Pressure After Apple Slashes Revenue Guidance
- BRIEF-Asia Pacific Silk Road Investment Co Announces Acquisition Of Sky State Holdings For Hk$25 Mln
- A Trio of Strong Performers to Consider
- One Thing To Remember About The Peking University Resources (Holdings) Company Limited (HKG:618) Share Price
- Calculating The Intrinsic Value Of Costco Wholesale Corporation (NASDAQ:COST)
- BRIEF-Xuancheng Valin Precision Technology's Shareholder To Unload Up To 2.4 Pct Between Mar 5 And Sept 1
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Opera Limited (OPRA) Investors With Losses to Contact its Attorneys: Important Class Action Deadline Approaching
- IAG CEO Walsh - No-deal Brexit would not impact passenger numbers
相关推荐:
- Margaux Resources Announces Collaboration with GoldSpot Discoveries and Spring Work Program on Cassiar Gold Project
- Investors Who Bought Gyldendal (OB:GYL) Shares Five Years Ago Are Now Up 120%
- For France's Macron, 2020 again brings rocky start, outlook
- Los Angeles Covid Warning: Brace For “Significant Transmission In The Upcoming Weeks,” According To Public Health Director
- HSBC, Standard Chartered Shares Plunge After Dividend Payment Cancellations
- NFL Secures Injunction Against 200 Unknown Defendants
- British currency exchange WorldFirst shuts U.S. operations - FT
- BRIEF-Qingdao Hanhe Cable Says It Wins State Grid's Bids For A Combined 470 Million Yuan
- Do Hedge Funds Love Brooge Energy Limited (BROG)?
- BRIEF-Majuperak Holdings Says Salween Azila Binti Ahmad Tauffik Re-Designated To Group CEO
- Livestock Diagnostics Market Worth $1.85 billion by 2027, Growing at a CAGR of 7.8% from 2019- Exclusive Report by Meticulous Research®
- Maybe the Coronavirus Didn’t End the Bull Market
- FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against HDFC Bank Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- Rental fleet collapse drags down U.S. vehicle sales
- Should You Buy AMD Stock?
- US colleges in the crosshairs as coronavirus fears swirl
- Visa's (V) Program to Aid Asia Pacific Startups Thrive Globally
- 5 Video Conferencing Stocks to Ride on Coronavirus Commotion
- AT&T Stock Falls 4%
- As Currency Values Deflate, Gold Sees Bright Horizon